Neuropharmacology is one of the most promising disciplines of pharmacology and neuroscience in terms of its long-term perspectives. This is because neurological and psychiatric diseases are amongst the less effectively treated disorders by the current therapeutic armada. There is therefore lots of room for major discoveries and for the development of novel therapeutic strategies. A M.Sc., Ph.D. or postdoctoral fellowship in our group could thus represent an important milestone preparing you to a variety of exciting careers.

As an example, please find below the career profile of some of the students and fellows that recently graduate from the Trudeau laboratory :

Annie Bergevin (M.Sc., pharmacology, 2001) : obtained a position with Novartis Pharma in Montreal in the drug regulation field.

Patrice Congar (Postdoctoral fellow, neuropharmacology, 2003) : obtained a permanent scientist position in a INRA research center in France in the Paris region.

François Michel (Ph.D., neuroscience, 2003) : after a postdoctoral fellowship in France,  he obtained a research engineer position at a INSERM research center in Marseille, France.

Mark Legault (Postdoctoral fellow, neuropharmacology, 2004) : obtained a position as a clinical research scientist with Lundbeck Canada, in Montreal. Is now with Pharmascience.

Gabriel Fortin (M.Sc., neuroscience, 2004) : completed a M.D. degree at the University of Ottawa and is now practicing medicine.

Caroline Forget (M.Sc., pharmacology, 2004) : obtained a research position at Painceptor, a biotechnology company in Montreal. She is now at CitoToxLAB north america.

Charbel Fawaz (M.Sc., neuroscience, 2006) : is presently chief of neurosurgery at Moncton hospital

Claudia Jomphe (Ph.D., pharmacology, 2006) : after completing a postdoctoral fellowship at the research center of AstraZeneca in Montreal, she worked for Pharsight Corporation, a company involved in drug development. She is now with Certara.

Fannie St-Gelais (Ph.D., neuroscience, 2006) : after a postdoctoral fellowship at Yale University in the United States, she now works for Health Canada in Ottawa.

Philippe Martel (M.Sc., pharmacology, 2006) : obtained a MD degree from the Université de Montréal and completed a residency in neurosurgery at McGill University in Montreal. He is now pursuing a fellowship at the University of Washington.

Stéphanie Fulton (Postdoctoral fellow, neuropharmacology, 2008) : is now an associate professor in the department of nutrition at the Université de Montréal.

Caroline Fasano (Postdoctoral fellow, neuropharmacology, 2009) : After completing a second postdoctoral fellow at McGill University in Montreal, she is now a clinical research assistant at the CHUM research center in Montreal.

Jose Alfredo Mendez (Postdoctoral fellow, neuropharmacology, 2009) : is now an associate professor at San Luis Potosi University in Mexico.

Gregory Dal Bo (Ph.D. sciences neurologiques, 2010): after a postdoctoral fellowship at McGill University in Montreal, he is now scientist at the Institut de Recherche Biomédicale des Armées in Paris, France.

Christian Kortleven (Ph.D. sciences neurologiques, 2011): after a postdoctoral fellowship at McGill University in Montreal and then at the Free University in Amsterdam, he is now a medical writer at Venn Life Sciences in the Netherlands.

Dominic Thibault (Ph.D. sciences neurologiques, 2012): completed a M.D. degree at the Université de Montréal.

Guillaume Fortin (Ph.D. pharmacology, 2014): is CEO and co-founder of Neurometrics.

Consiglia Pacelli (Postdoctoral fellow, neuropharmacology, 2014): is now a scientist at the University of Foggia in Italy.